| Name | Title | Contact Details |
|---|---|---|
Keith Halcomb |
Supply Chain Manager | Profile |
Tom Baldwin |
Vice President, Total Rewards | Profile |
Stephanie Cade |
Director of Human Resources | Profile |
Amanda Hargreaves |
Vice President, Human Resources | Profile |
Greg Fredericks |
Vice President Human Resources | Profile |
Advanced Accelerator Applications is a pharmaceutical group specialized in the field of nuclear medicine.
Fougera Pharmaceuticals is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Theseus is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Theseus is developing next-generation tyrosine kinase inhibitors (TKIs): "pan-variant" targeted therapies that address all major drug resistance mutations. Theseus` lead product candidate, THE-630, is a pan-variant KIT inhibitor for the treatment of patients with advanced gastrointestinal stromal tumors (GIST), whose cancer has developed resistance to earlier lines of kinase inhibitor therapy. Theseus is also developing a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).
R2P creates a unique physical therapy experience, offering our blend of performance, return to sport, physical therapy, dry needling and injury prevention.
Resau Medisca Network Inc. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.